Kamu erişimi zorunlu olan makaleler - Dean A RegierDaha fazla bilgi edinin
Hiçbir yerde sunulmuyor: 22
Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes
E Pleasance, E Titmuss, L Williamson, H Kwan, L Culibrk, EY Zhao, ...
Nature Cancer 1 (4), 452-468, 2020
Zorunlu olanlar: US National Institutes of Health, Canadian Institutes of Health Research …
Bayesian and classical estimation of mixed logit: an application to genetic testing
DA Regier, M Ryan, E Phimister, CA Marra
Journal of health economics 28 (3), 598-610, 2009
Zorunlu olanlar: Canadian Institutes of Health Research, Genome Canada
Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: willingness to pay from families of affected children
DA Regier, JM Friedman, N Makela, M Ryan, CA Marra
Clinical genetics 75 (6), 514-521, 2009
Zorunlu olanlar: Canadian Institutes of Health Research, Genome Canada
Perspectives toward oral mucositis prevention from parents and health care professionals in pediatric cancer
MC Ethier, DA Regier, D Tomlinson, P Judd, J Doyle, A Gassas, A Naqvi, ...
Supportive Care in Cancer 20, 1771-1777, 2012
Zorunlu olanlar: Canadian Institutes of Health Research
Task complexity and response certainty in discrete choice experiments: an application to drug treatments for juvenile idiopathic arthritis
DA Regier, V Watson, H Burnett, WJ Ungar
Journal of Behavioral and Experimental Economics 50, 40-49, 2014
Zorunlu olanlar: Canadian Cancer Society
Economic evaluations of next-generation precision oncology: a critical review
D Weymann, R Pataky, DA Regier
JCO Precision Oncology 2, 1-23, 2018
Zorunlu olanlar: Canadian Cancer Society
Decision making in pediatric oncology: evaluation and incorporation of patient and parent preferences
L Sung, DA Regier
Pediatric blood & cancer 60 (4), 558-563, 2013
Zorunlu olanlar: Canadian Institutes of Health Research
Balancing uncertainty with patient autonomy in precision medicine
S Pollard, S Sun, DA Regier
Nature Reviews Genetics 20 (5), 251-252, 2019
Zorunlu olanlar: Canadian Cancer Society, Canadian Institutes of Health Research, Genome Canada
Public perceptions of the benefits and risks of newborn screening
FA Miller, RZ Hayeems, Y Bombard, C Cressman, CJ Barg, JC Carroll, ...
Pediatrics 136 (2), e413-e423, 2015
Zorunlu olanlar: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Discrete choice experiment produced estimates of acceptable risks of therapeutic options in cancer patients with febrile neutropenia
L Sung, SM Alibhai, MC Ethier, O Teuffel, S Cheng, D Fisman, DA Regier
Journal of clinical epidemiology 65 (6), 627-634, 2012
Zorunlu olanlar: Canadian Institutes of Health Research
Theoretical foundations of MCDA
DA Regier, S Peacock
Multi-criteria decision analysis to support healthcare decisions, 9-28, 2017
Zorunlu olanlar: Canadian Cancer Society
Developing data sharing models for health research with real-world data: a scoping review of patient and public preferences
A Hermansen, DA Regier, S Pollard
Journal of Medical Systems 46 (12), 86, 2022
Zorunlu olanlar: Genome Canada
Patient and public preferences for being recontacted with updated genomic results: a mixed methods study
C Mighton, M Clausen, A Sebastian, SM Muir, S Shickh, NN Baxter, ...
Human Genetics 140, 1695-1708, 2021
Zorunlu olanlar: Canadian Cancer Society, Canadian Institutes of Health Research
Tools for the economic evaluation of precision medicine: A scoping review of frameworks for valuing heterogeneity-informed decisions
RE Pataky, S Bryan, M Sadatsafavi, S Peacock, DA Regier
Pharmacoeconomics 40 (10), 931-941, 2022
Zorunlu olanlar: Canadian Cancer Society, Canadian Institutes of Health Research
Health-related quality of life data collected in chimeric antigen receptor T-cell (CAR-T) therapy clinical trials
AJN Raymakers, DA Regier, SJ Peacock, CL Freeman
Journal of Cancer Policy 30, 100304, 2021
Zorunlu olanlar: Michael Smith Foundation for Health Research
Early-phase clinical trials and reimbursement submissions to the Pan-Canadian oncology drug review
AJN Raymakers, KM Jenei, DA Regier, MM Burgess, SJ Peacock
Pharmacoeconomics 39 (3), 373-377, 2021
Zorunlu olanlar: Canadian Institutes of Health Research, Michael Smith Foundation for Health …
Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma
L Calvente, R Tremblay‐LeMay, W Xu, FC Chan, M Hong, T Zhang, ...
British Journal of Haematology 190 (6), 864-868, 2020
Zorunlu olanlar: Genome Canada
Utility estimates of disease-specific health states in prostate cancer from three different perspectives
KS Gries, DA Regier, SD Ramsey, DL Patrick
Applied Health Economics and Health Policy 15, 375-384, 2017
Zorunlu olanlar: US National Institutes of Health
Provider preferences for resolving uncertainty and avoiding harms in precision medicine: a discrete choice experiment
N Hendrix, DA Regier, J Chatterjee, DS Dhanda, A Basu, DL Veenstra, ...
Personalized Medicine 17 (5), 389-398, 2020
Zorunlu olanlar: US National Institutes of Health
SecureConsent: A Blockchain-Based Dynamic and Secure Consent Management for Genomic Data Sharing
IT Javed, V Lemieux, DA Regier
2024 International Conference on Smart Applications, Communications and …, 2024
Zorunlu olanlar: Genome Canada
Yayıncılık ve maddi kaynak bilgileri otomatik olarak bir bilgisayar programı tarafından belirlenmektedir